Published in C R Seances Soc Biol Fil on January 01, 1978
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients. Circulation (2004) 2.12
Binding of hormone to tissue: the first step in polypeptide hormone action. Proc Natl Acad Sci U S A (1966) 1.96
A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet (1998) 1.74
Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia (2010) 1.59
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med (1995) 1.58
Efavirenz associated with corticosteroids in patients with previous severe hypersensitivity reaction due to nevirapine. AIDS (2000) 1.38
Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psychiatry (1994) 1.28
Recolonization of the subgingival microflora after scaling and root planing in human periodontitis. J Periodontol (1990) 1.22
Interaction of fragments B and C of tetanus toxin with neural and thyroid membranes and with gangliosides. J Biol Chem (1980) 1.18
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Thromb Haemost (2001) 1.17
Guanylate cyclase in Escherichia coli. Purification and properties. J Biol Chem (1975) 1.10
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report. Haemophilia (2010) 1.09
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes (Lond) (2010) 1.09
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. J Thromb Haemost (2006) 1.07
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Oncogene (2006) 1.07
Hepatitis B immunisation with a reduced number of doses in newborn babies and children. Lancet (1985) 1.04
Comparison of two systems for identification of anaerobic bacteria. Eur J Clin Microbiol (1985) 1.03
Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH. Development (1998) 1.02
Two-dose hepatitis B immunisation regimen for infants. Lancet (1985) 1.00
The pleiotropic ts15 mutation of E. coli is an IS1 insertion in the rho structural gene. Genetics (1983) 0.99
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. J Thromb Haemost (2009) 0.98
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Osteoarthritis Cartilage (2013) 0.98
Thyroglobulin interactions with thyroid plasma membranes. The existence of specific receptors and their potential role. J Biol Chem (1979) 0.97
The nature of inhibition of mitochondrial malate dehydrogenase by thyroxine, iodine cyanide and molecular iodine. Eur J Biochem (1970) 0.97
The purification and properties of a thyroid-stimulating factor isolated from Clostridium perfringens. J Biol Chem (1967) 0.97
[In vitro biosynthesis of double-labelled hormones in thyroid slices. II. Biosynthesis of non-iodinated pre-thyroglobulin]. Biochim Biophys Acta (1965) 0.95
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement. Haemophilia (2004) 0.95
Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries. Haemophilia (2002) 0.94
A phospholipase specific for sphingomyelin from Clostridium perfringens. J Biol Chem (1968) 0.94
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors. Haemophilia (2006) 0.93
Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease. Hum Genet (1996) 0.93
Role of phospholipids in the structure and function of the thyrotropin receptor. J Biol Chem (1979) 0.93
Diamine oxidase in rat small bowel: distribution in different segments and cellular location. Enzyme (1984) 0.92
Action of phospholipase C on the thyroid. Abolition of the response to thyroid-stimulating hormone. J Biol Chem (1967) 0.92
Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost (2000) 0.91
Mechanism of thyroid-stimulating hormone action. Studies with dibutyl 3',5'-adenosine monophosphate and lecithinase C. J Biol Chem (1967) 0.91
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study. Haemophilia (2013) 0.91
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors. Haemophilia (2007) 0.91
Characterization of phosphate residues on thyroglobulin. J Biol Chem (1987) 0.90
The influence of cyclic GMP on polypeptide synthesis in a cell-free system derived from wheat embryos. Biochem Biophys Res Commun (1974) 0.90
High Th1-type cytokine serum levels in patients with infectious mononucleosis. Acta Virol (2004) 0.90
Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients. HIV Clin Trials (2001) 0.89
Dansylated thyrotropin as a probe of hormone-receptor interactions. J Biol Chem (1979) 0.89
Thyrotropin receptors and gangliosides. Adv Exp Med Biol (1980) 0.88
Guanylate cyclase activity in Escherichia coli mutants defective in adenylate cyclase. J Bacteriol (1981) 0.88
Thyroglobulin interactions with thyroid membranes. Relationship between receptor recognition of N-acetylglucosamine residues and the iodine content of thyroglobulin preparations. J Biol Chem (1981) 0.87
Demonstration of a Ca2+ requirement for thyroglobulin dimerization and export to the golgi complex. Eur J Biochem (1998) 0.87
Modulation of the carbohydrate moiety of thyroglobulin by thyrotropin and calcium in Fisher rat thyroid line-5 cells. J Biol Chem (1992) 0.87
The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists. Endocr Relat Cancer (2008) 0.87
Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency. Haematologica (2001) 0.86
Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment. Horm Res (1998) 0.86
European curriculum for thrombosis and haemostasis. Haemophilia (2009) 0.86
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy). HIV Clin Trials (2004) 0.85
Characterization of the rho genes of Neisseria gonorrhoeae and Salmonella typhimurium. J Bacteriol (1993) 0.85
Identification of alternative splicing of spinocerebellar ataxia type 2 gene. Gene (2001) 0.85
Polyglutamine-mediated aggregation and cell death. Biochem Biophys Res Commun (2000) 0.85
Yotiao protein, a ligand for the NMDA receptor, binds and targets cAMP-dependent protein kinase II(1). FEBS Lett (1999) 0.85
Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement. Cancer (2000) 0.85
Recommendations for assessment, monitoring and follow-up of patients with haemophilia. Haemophilia (2011) 0.84
Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A. J Thromb Haemost (2012) 0.84
Accelerated schedule of hepatitis B vaccination in patients with hemophilia. J Med Virol (1993) 0.84
Follicular thyroglobulin (TG) suppression of thyroid-restricted genes involves the apical membrane asialoglycoprotein receptor and TG phosphorylation. J Biol Chem (1999) 0.83
The expression of the sarco/endoplasmic reticulum Ca2+-ATPases in thyroid and its down-regulation following neoplastic transformation. J Mol Endocrinol (2003) 0.83
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia (2011) 0.83
Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line. Oncogene Res (1988) 0.83
Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates. Thromb Haemost (1994) 0.82
Epidermal growth factor receptor in human brain tumors. J Endocrinol Invest (1992) 0.82
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. Biochimie (1999) 0.82
The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates. Biochem Biophys Res Commun (1999) 0.82
Adenyl-cyclase in a transplantable thyroid tumor: loss of ability to respond to TSH. Endocrinology (1972) 0.82
Bovine thyroglobulin. 27 S iodoprotein interactions with thyroid membranes and formation of a 27 S iodoprotein in vitro. J Biol Chem (1982) 0.81
Thyroglobulin binding and TSH regulation of the RHL-1 subunit of the asialoglycoprotein receptor in rat thyroid. Biochimie (1999) 0.81
The size of the community rather than its geographical location better defines the risk of iodine deficiency: results of an extensive survey in Southern Italy. J Endocrinol Invest (2013) 0.81
In vitro synthesis of a thyroglobulin precursor by porcine thyroid membrane-bound ribosomes in a heterologous cell-free system. J Biol Chem (1975) 0.81
Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemost (1994) 0.81
Neonatal bleeding in haemophilia: a European cohort study. Br J Haematol (2011) 0.81
The methyl xanthines--a new class of goitrogens. Endocrinology (1969) 0.81
Characterization of the heavy form (9S) of mitochondrial malate dehydrogenase. Eur J Biochem (1970) 0.80
Inhibitors in haemophilia B: the Italian experience. Haemophilia (2013) 0.80
[Guanyl cyclase in Escherichia coli. II. Identification and characteristics on the enzyme inhibitor]. C R Seances Soc Biol Fil (1978) 0.80
Resistance to activated protein C in adults with a history of juvenile transient ischemic attacks. Thromb Haemost (1996) 0.79
Relationship between angiotensin-converting enzyme gene polymorphism and insulin resistance in never-treated hypertensive patients. J Clin Endocrinol Metab (2001) 0.79
Mapping of human thyroglobulin gene on the long arm of chromosome 8 by in situ hybridization. Hum Genet (1985) 0.79
Epidermal growth factor receptor and thyrotropin response in human thyroid tissues. J Endocrinol Invest (1990) 0.79
Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness. Cancer Res (1975) 0.79
Stimulation of polypeptide synthesis by cyclic 3'-5'-guanosine monophosphate. Arch Biochem Biophys (1973) 0.79
Serum withdrawal induces apoptotic cell death in Ki-ras transformed but not in normal differentiated thyroid cells. Biochem Biophys Res Commun (1995) 0.79